A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial

Peer Review reports

Original Submission
23 Jul 2014	Submitted	Original manuscript
3 Sep 2014	Reviewed	Reviewer Report - Everardo Saad
4 Sep 2014	Author responded	Author comments - Samal Gunatilake
Resubmission - Version 2
4 Sep 2014	Submitted	Manuscript version 2
Publishing
9 Sep 2014	Editorially accepted
19 Sep 2014	Article published	10.1186/1745-6215-15-367

Back to article page